Klinikum der Universität München, Medizinische Klinik und Poliklinik III

München 81377

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer Stage II, Colorectal Cancer Stage III, Pancreatic Cancer Non-resectable

Studies at this site

• Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy — Completed
• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — Completed